Peter J. McDonnell, MD

“[Gene therapy may] dramatically reduce frequency of treatments.”

Peter McDonnell, MD, shares his thoughts on Omar R. Shakir's, MD, MBA, article on office-based vitrectomy surgery.

With 37 years of clinical trial experience, Peter J. McDonnell, MD, offer some tips.

As ophthalmology continues to advance, there is still room for more ocular cancer understanding and research.

VR will have very useful applications in many fields. One of those fields is ophthalmology.